NMDA receptor antagonists: Latest News, Top Stories & Analysis

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), in collaboration with Nephron Pharmaceuticals, has announced the development of a novel formulation of IV Ketamine, known as HTX-100, that achieves a …

Regional

NRx Pharmaceuticals Launches HOPE Therapeutics, Aims to Address Suicidal Depression

February 5, 2024February 5, 2024 - by Timothy Alexander

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has announced the incorporation of HOPE Therapeutics™, a biotechnology company with an ambitious goal: to offer a lifesaving treatment for patients grappling …